Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
C. Rodríguez Escolar, M.L. Fidalgo García, S Rubio Cebrián.
Análisis costeefectividad del alendronato frente a placebo en la prevención de la fractura de cadera.
Aten Primaria, 24 (1999), pp. 390-395
[2.]
H. Knobel, A. Díez, D. Arnau, A. Alier, I. Ibáñez, I. Campodarve, et al.
Secuelas de las fracturas osteoporóticas de fémur en Barcelona.
Med Clin (Barc), 98 (1992), pp. 441-444
[3.]
P.D. Ross, A. Santora, A.J. Yates.
Epidemiology and consequences of osteoporotic fractures.
The aging skeleton, pp. 339-347
[4.]
D. Black, S. Cummings, D. Karp, A. Cauly, D. Thompson, M. Nevitt, et al.
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures.
Lancet, 348 (1996), pp. 1535-1541
[5.]
U.A. Liberman, S.R. Weiss, J. Broll, H.W. Minnie, H. Quan, a.l. Bell NH et.
for the Alendronate Phase III Osteoporosis Treatment Study Group. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis.
N Engl J Med, 333 (1995), pp. 1437-1443
[6.]
H.K. Gennat, C. Cooper, G. Poor, I. Reid, G. Ehrlich, J. Kanis, et al.
Interim report and recommendations of the World Health Organization Task-Force on global strategy for osteoporosis.
Osteopor Int, 9 (1999), pp. 259-264
[7.]
B. Jonnsson, C. Christiansen, O. Johnell, J. Hebrandt.
Cost-effectiveness of fractures prevention in established osteoporosis.
Osteopor Intern, 5 (1995), pp. 136-142
[8.]
National Osteoporosis Foundation.
Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis.
Osteopor Intern, 8 (1998), pp. 1-88
[9.]
D. Mareshall, O. Johnell, H. Wedell.
Metaanalysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures.
MMJ, 312 (1999), pp. 1254-1259
[10.]
L.J. Melton, E.J. Atkinson, C. Cooper, O’-Fakkib-win, B.I. Riggs.
Vertebral fractures predict subsequent fractures.
Osteopor Int, 10 (1999), pp. 214-221
Copyright © 2000. Elsevier España, S.L.. Todos los derechos reservados
